Results 61 to 70 of about 78,093 (265)

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

open access: yesObesity, EarlyView.
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu   +13 more
wiley   +1 more source

The impact of cataract surgery on tear film physiology: signs and symptoms, progression and treatment

open access: yesFrontiers in Medicine
PurposeThis study aimed to revise data published in the literature on the effects of cataract surgery on tear film characteristics, in relation to personal clinical surgical experience.MethodsA search was undertaken using PubMed (all years). Search terms
Alessia Nuzzi   +2 more
doaj   +1 more source

Evaluating the Evolving Real‐World Adverse Events of GLP‐1RAs Using FDA Adverse Event Reporting System (FAERS)

open access: yesObesity, EarlyView.
Web portal for interrogating Adverse Events of GLP‐1 RA in diabetes vs weight control/obesity. ABSTRACT Objective This study aimed to assess the spectrum and frequency of adverse events (AEs) linked to glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) using the US FDA Adverse Event Reporting System (FAERS).
David Stone   +3 more
wiley   +1 more source

CATARACT SURGERY [PDF]

open access: yesBritish Journal of Ophthalmology, 1959
J, BARRAQUER, J, BOBERG-ANS
openaire   +2 more sources

Fiber Bragg Grating Force Sensors for Minimally Invasive Surgery: State of the Art, Challenges, and Opportunities

open access: yesSmartBot, EarlyView.
This article reviews the application of fiber Bragg grating (FBG) technology for precise force sensing in minimally invasive surgery. It outlines the fundamental working principles and algorithms used to interpret sensor data. The text surveys clinical applications across various medical fields, such as ophthalmology and vascular intervention (Table of
Shiyuan Dong   +9 more
wiley   +1 more source

Comparison of Post-Operative Outcomes between IOP-20 and IOP-50 in Phacoemulsification with Active Fluidics System: Randomized Single Blinded Trial

open access: yesClinical Ophthalmology
Chandrashekhar M Wavikar,1 Mamta N Tanna,1 Gargi C Wavikar,2 Chandrashekhar B Kale,1 Maninder Singh Setia3 1Department of Ophthalmology, Wavikars Eye Hospital and Wavikar Eye Institute, Thane, Maharashtra, India; 2Department of Ophthalmology, Sri ...
Wavikar CM   +4 more
doaj  

Artificial intelligence in ophthalmology: from innovation to clinical integration

open access: yesFrontiers in Ophthalmology
Artificial intelligence (AI) has emerged as a transformative force in modern ophthalmology, enabling rapid advances in disease detection, clinical decision support, workflow optimization, and tele-ophthalmology.
Bharat Gurnani, Kirandeep Kaur
doaj   +1 more source

CATARACT SURGERY [PDF]

open access: yesBritish Journal of Ophthalmology, 1964
J, Barraquer, H F, Hill
openaire   +2 more sources

Nonthermal plasma approaches for combating implant‐associated infections: A compendious review

open access: yesVIEW, EarlyView.
Implant‐associated infections pose serious clinical challenges. Non‐thermal plasma (NTP) modifications overcome this bottleneck in distinct ways relative to traditional sterilization methods. Gas‐phase plasmas generate highly energetic species, UV radiation and reactive oxygen/nitrogen species (RONS), which alter the implant surface properties.
A. M. Trimukhe   +8 more
wiley   +1 more source

Decline in unmet needs for cataract surgery among the ageing population in India: findings from LASI, wave-1

open access: yesFrontiers in Health Services
IntroductionCataracts are the leading cause of blindness among older people, but they can be treated with corrective surgery. India boasts the oldest blindness control programme in the world.
Sasmita Das   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy